Urology Doctors in Garland, TX Accepting Medicare

3 Urology doctors found. Showing 1 - 3

Dr. Gregory Charles Lieser, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6460 Naaman Forest Blvd, Garland, TX 75044 Phone: 972-494-6764    Fax: 972-494-6893

Frank Freeman Splann Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 2241 Peggy Ln, Garland, TX 75042 Phone: 972-276-6191    Fax: 972-494-3712

Keith D Newman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 618 Clara Barton Blvd, Ste 3, Garland, TX 75042 Phone: 972-494-6764    Fax: 972-454-6893

News Archive

JAX professor receives $5.4 million grant to study 'cognitive resilience' to Alzheimer's disease

A new five-year grant totaling $5,382,423 to Jackson Laboratory Assistant Professor Catherine Kaczorowski will fund research to explore why some people with a family history of Alzheimer's disease, and even brain changes associated with the disease, nevertheless manage to maintain their cognitive capabilities.

Patients checking into a top rated hospital have a 27 percent lower chance of mortality

Patients checking into a hospital rated in the top five percent in the country have, on average, a 27 percent lower chance of mortality and a 14 percent lower risk of complications, according to a study released today by HealthGrades, the leading independent healthcare ratings company.

Suspended animation in humans successfully tried for the first time

Researchers from the University of Maryland School of Medicine, for the first time have put a patient in "suspended animation" successfully. Using this method, they lowered the body temperature of the human patient for the first time. This would help surgeons to prolong the time of surgery to correct traumatic injuries. The plan of their feat was published in the latest issue of the New Scientist last week.

Promising preliminary results from ProFibrix' Phase II trial of hemostat Fibrocaps

ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.

Read more Medical News

› Verified 5 days ago